| SYMPOSIUM REVIEW: Gating of two pore domain potassium channels A Mathie, E Al‐Moubarak, EL Veale The Journal of physiology 588 (17), 3149-3156, 2010 | 112 | 2010 |
| Influence of the N terminus on the biophysical properties and pharmacology of TREK1 potassium channels EL Veale, E Al-Moubarak, N Bajaria, K Omoto, L Cao, SJ Tucker, ... Molecular pharmacology 85 (5), 671-681, 2014 | 68 | 2014 |
| Recovery of current through mutated TASK3 potassium channels underlying Birk Barel syndrome EL Veale, M Hassan, Y Walsh, E Al-Moubarak, A Mathie Molecular pharmacology 85 (3), 397-407, 2014 | 48 | 2014 |
| Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutant E Al-Moubarak, HA Shiels, Y Zhang, C Du, O Hanington, SC Harmer, ... Cellular and Molecular Life Sciences 78, 7899-7914, 2021 | 22 | 2021 |
| A homology model for Clostridium difficile methionyl tRNA synthetase: active site analysis and docking interactions E Al-Moubarak, C Simons Journal of molecular modeling 17, 1679-1693, 2011 | 15 | 2011 |
| Serine mutation of a conserved threonine in the hERG K+ channel S6-pore region leads to loss-of-function through trafficking impairment E Al-Moubarak, Y Zhang, CE Dempsey, H Zhang, SC Harmer, JC Hancox Biochemical and Biophysical Research Communications 526 (4), 1085-1091, 2020 | 11 | 2020 |
| In silico Exploration of Interactions Between Potential COVID-19 Antiviral Treatments and the Pore of the hERG Potassium Channel—A Drug Antitarget E Al-Moubarak, M Sharifi, JC Hancox Frontiers in Cardiovascular Medicine 8, 645172, 2021 | 7 | 2021 |
| Pharmacologically reversible, loss of function mutations in the TM2 and TM4 inner pore helices of TREK-1 K2P channels E Al-Moubarak, EL Veale, A Mathie Scientific reports 9 (1), 12394, 2019 | 7 | 2019 |
| Evaluating pro-arrhythmogenic effects of the T634S-hERG mutation: insights from a simulation study W Hu, W Zhang, K Zhang, E Al-Moubarak, Y Zhang, SC Harmer, ... Interface Focus 13 (6), 20230035, 2023 | 2 | 2023 |
| Inhibition of hERG potassium channels by the polycylic aromatic hydrocarbon phenanthrene E Al-Moubarak, H Shiels, Y Zhang, C Du, C Dempsey, J Hancox Biophysical Journal 118 (3), 109a, 2020 | 2 | 2020 |
| Regulation of TREK1 two pore domain potassium channels by citalopram E Al‐Moubarak, EL Veale, A Mathie The FASEB Journal 27, 913.31-913.31, 2013 | 2 | 2013 |
| Enhancement of Current through Trek1 Two Pore Domain Channels by Flufenamic Acid E Al-Moubarak, A Mathie Biophysical Journal 106 (2), 748a, 2014 | | 2014 |
| Molecular Pharmacology Fast Forward. Published on February 7, 2014 as doi: 10.1124/mol. 113.091199 EL Veale, E Al-Moubarak, N Bajaria, K Omoto, L Cao, SJ Tucker, ... | | 2014 |
| A homology model for methionyl tRNA synthetase: active site analysis and docking interactions C Simons, E Al-Moubarak Springer-Verlag, 2011 | | 2011 |
| Inhibition of The hERG Potassium Channel By The Polycyclic Aromatic Hydrocarbon Pollutant Phenanthrene E Al-Moubarak, HA Shiels, Y Zhang, C Du, O Hanington, SC Harmer, ... | | |
